High Follistatin Predicts Poor Cardiometabolic Outcomes High Follistatin Predicts Poor Cardiometabolic Outcomes

Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.First Look
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news